Page 24 - Central Drug Authority Annual Report 2021
P. 24
3. CDA SECRETARIAT
7KH $FW SURYLGHV IRU WKH HVWDEOLVKPHQW RI WKH &'$ 1R ([HFXWLYH 'LUHFWRU RI WKH &'$ DV SURYLGHG IRU LQ WKH
VHFUHWDULDW ZKLFK DFFRXQWV WR WKH &'$ DQG LV ORFDWHG LQ $FW KDV EHHQ DSSRLQWHG VLQFH WKH LQFHSWLRQ RI WKH &'$
WKH 'HSDUWPHQW RI 6RFLDO 'HSDUWPHQW WKH OHDG 7KH FDSDFLW\ RI WKH 6HFUHWDULDW LQ WKHUHIRUH QRW RSWLPDO
GHSDUWPHQW LQ WKH ˉHOG RI VXEVWDQFH DEXVH $Q LPSRUWDQW 7KH 6HFUHWDULDW LV IXOO\ DFFRXQWDEOH WR WKH GHSDUWPHQW
IXQFWLRQ RI WKH &'$ LV WR PRQLWRU WKH LPSOHPHQWDWLRQ RI UDWKHU WKDQ WKH &'$ 7KLV SRVLWLRQLQJ RI WKH &'$ DQG LWV
WKH 1'03 WR IDFLOLWDWH DQG SURPRWH DQ LQWHJUDWHG VHFUHWDULDW ZKLFK LQ HIIHFW DQG LQ SUDFWLFH KDV EHFRPH
DSSURDFK WR VHUYLFH GHOLYHU\ DQG WR FRRUGLQDWH VXEVHUYLHQW WR WKH 'LUHFWRUDWH RI WKH GHSDUWPHQW KDG
SURJUDPPHV DLPHG DW WKH FRQWURO RI VXEVWDQFHV IRU DQG FRQWLQXHV WR KDYH D QHJDWLYH HIIHFW RQ WKH
PHGLFDO DQG VFLHQWLˉF XVH LQ DOO VSKHUHV RI JRYHUQPHQW IXQFWLRQLQJ RI WKH &'$ 6HYHUDO VWXGLHV DQG
DQG FLYLO VRFLHW\ 7KH &'$ WKHUHIRUH IDFLOLWDWHV LQYHVWLJDWLRQV KDYH EHHQ GRQH ZKLFK SURSRVH FRQFUHWH
FRRSHUDWLRQ EHWZHHQ JRYHUQPHQW DQG VWDNHKROGHUV LQ PHDVXUHV IRU WKH VWUHQJWKHQLQJ RI WKH 6HFUHWDULDW EXW
WKH ˉHOG RI VXEVWDQFHV LQFOXGLQJ WKH XVH DQG DEXVH RI WKLV KDV QRW EHHQ HIIHFWHG 7KLV ZLOO QHHG WR EH RQH RI
VXEVWDQFHV DQG WKH PDQDJHPHQW RI OLFLW DQG LOOLFLW WKH NH\ SULRULWLHV RI WKH WK &'$ ZKLFK ZLOO EH
VXEVWDQFHV LQDXJXUDWHG LQ WKH QH[W ˉQDQFLDO \HDU
7KH &'$ 6HFUHWDULDW WKXV SHUIRUPV WKH ZRUN LQFLGHQWDO WR
WKH IXQFWLRQV RI WKH &'$ DQG SURYLGHV DGPLQLVWUDWLYH
DQG RWKHU VXSSRUW DV PD\ EH UHTXLUHG E\ WKH &'$ 7KH
6HFUHWDULDW PXVW HQVXUH WKDW WKH GD\ WR GD\ ZRUN RI WKH
&'$ LV FDUULHG RXW LQ OLQH ZLWK WKH UHTXLUHPHQWV RI WKH
$FW DQG WKH 1'03 7KH 6HFUHWDULDW DOVR SURYLGHV
WHFKQLFDO DQG DGPLQLVWUDWLYH VXSSRUW WR WKH &'$ DQG LWV
LQVWLWXWLRQDO VXSSRUW VWUXFWXUHV 7KH FDSDFLWDWLRQ RI WKH
&'$ VHFUHWDULDW LV FULWLFDO WR WKH &'$ GHOLYHULQJ RQ LWV
PDQGDWH
4. COMPOSITION AND MEMBERSHIP OF THE CDA
7KH 3UHYHQWLRQ RI DQG 7UHDWPHQW IRU 6XEVWDQFH $EXVH 0HPEHUV IURP WKH SULYDWH VHFWRU ZHUH QRPLQDWHG DQG
$FW $FW RI DQG WKH 1'03 WKHQ VHOHFWHG E\ WKH 3RUWIROLR &RPPLWWHH RQ 6RFLDO
SUHVFULEHV WKDW WKH &'$ EH FRPSRVHG RI PHPEHUV 'HYHORSPHQW DQG WKH 6HOHFW &RPPLWWHH RQ 6RFLDO
UHSUHVHQWDWLYHV RI WKH GHVLJQDWHG JRYHUQPHQW 6HUYLFHV 5HSUHVHQWDWLYHV IURP JRYHUQPHQW
GHSDUWPHQWV DQG GUXJ H[SHUWV +RZHYHU LQ WKH \HDU GHSDUWPHQWV ZHUH QRPLQDWHG E\ WKHLU UHVSHFWLYH
XQGHU UHYLHZ WKH &'$ KDG PHPEHUV FRQVLVWLQJ RI PLQLVWHUV DQG DSSRLQWHG E\ WKH 0LQLVWHU RI 6RFLDO
GHSDUWPHQWDO UHSUHVHQWDWLYHV DQG GUXJ H[SHUWV 7KLV 'HYHORSPHQW DV VWLSXODWHG E\ OHJLVODWLRQ
ZDV GXH WR WKH IDFW WKDW VRPH GHSDUWPHQWV KDG QRW .
QRPLQDWHG UHSUHVHQWDWLYHV VRPH KDG PHUJHG DQG
VRPH KDG QRW ˉOOHG YDFDQFLHV 6RPH GUXJ H[SHUWV
UHVLJQHG SDVVHG RQ RU DEVFRQGHG
22 Annual Report 2020/2021 Central Drug Authority